Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 9, 2017
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results
SAN DIEGO, May 9, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today ...
May 9, 2017
Rockwell Medical Reports First Quarter Results
WIXOM, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
May 9, 2017
Ocera Therapeutics Reports First Quarter 2017 Financial Results and Provides Clinical Update
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., May 09, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (OCRX), a clinical stage biopharmaceutical company focused on ...
May 9, 2017
Foamix Reports First Quarter 2017 Financial Results and Provides Business Update
REHOVOT, Israel, May 9, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd.(FOMX) ("Foamix Pharmaceuticals" or the "Company"), a clinical stage specialty pharmaceutical company focused on developing and commercializing ...
May 9, 2017
Heron Therapeutics to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on developing novel best-in-class treatment solutions to address some of the biggest unmet patient needs, announced ...
May 9, 2017
Prothena Reports First Quarter 2017 Financial Results and Provides R&D Update
DUBLIN, Ireland, May 09, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
May 9, 2017
Mateon Provides Corporate Update and Reports First Quarter 2017 Financial Results
SOUTH SAN FRANCISCO, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment ...
May 9, 2017
Scottish Medicines Consortium Approves Santhera's Raxone® (idebenone) for Restricted Use in Patients with LHON within NHS Scotland
Liestal, Switzerland, May 9, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces approval by the Scottish Medicines Consortium for restricted use of Raxone® (idebenone) in patients with LHON, ...
May 9, 2017
Addex ADX71441 Demonstrates Preclinical Analgesic Effects
Geneva, Switzerland, 9 May 2017 - Addex Therapeutics (ADXN.SW) announced today positive results from multiple preclinical studies of ADX71441, a positive allosteric modulator (PAM) of ...
May 9, 2017
Gemphire Announces First Quarter 2017 Financial Results and Provides Corporate Update
LIVONIA, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
May 9, 2017
Sierra Oncology Reports First Quarter 2017 Results
VANCOUVER, May 9, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics ...
May 9, 2017
BioTime Announces New Positive Data from OpRegen® Trial in Dry-AMD
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced new data from the Phase I/IIa clinical ...
May 9, 2017
Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that ...
May 9, 2017
Pharma Industry Veteran Dr. George Milne Joins Aurinia’s Board of Directors
VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market, today ...
May 9, 2017
Aimmune Therapeutics to Present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16
BRISBANE, Calif.--(BUSINESS WIRE) -- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy) treatments for life-threatening food allergies, today announced that CEO ...
May 9, 2017
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2017 Financial Results
AUSTIN, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino ...
May 9, 2017
Rockwell Medical Shareholders Express Support for the Election of David Domzalski
WIXOM, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI) today released several statements of support from shareholders in connection with the Company’s ...
May 8, 2017
Pernix Therapeutics to Report First Quarter 2017 Financial Results on Monday, May 15
MORRISTOWN, N.J., May 08, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) a specialty pharmaceutical company, announced today that the Company will report financial ...
May 8, 2017
Aimmune Therapeutics Announces First Quarter 2017 Financial Results
Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy) treatments for life-threatening food allergies, today announced financial results for first quarter ...
May 8, 2017
Achaogen Reports First Quarter 2017 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
Page 136 of 138